$228 Million is the total value of Eversept Partners, LP's 63 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 62.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $26,164,800 | +221.5% | 90,000 | +200.0% | 11.48% | +208.5% |
| ZGNX | Buy | ZOGENIX INC | $20,796,238 | +211.9% | 419,279 | +178.0% | 9.13% | +199.3% |
| RCM | Sell | R1 RCM INC | $17,120,484 | +9.1% | 1,685,087 | -6.8% | 7.51% | +4.7% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $16,200,039 | +1039.7% | 995,700 | +116.5% | 7.11% | +993.8% |
| SNY | Buy | SANOFIsponsored adr | $12,546,552 | +47.2% | 280,872 | +31.9% | 5.51% | +41.3% |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $11,745,720 | +13.9% | 289,284 | +14.5% | 5.16% | +9.3% |
| MRK | New | MERCK & CO INC | $10,555,876 | – | 147,800 | +100.0% | 4.63% | – |
| RDUS | Buy | RADIUS HEALTH INC | $9,416,058 | -31.8% | 528,992 | +12.9% | 4.13% | -34.6% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $9,269,252 | +56.6% | 48,092 | +38.1% | 4.07% | +50.3% |
| TLGT | TELIGENT INC NEW | $8,342,787 | +14.2% | 2,112,098 | 0.0% | 3.66% | +9.5% | |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $7,429,762 | -51.5% | 120,711 | -46.8% | 3.26% | -53.5% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $6,814,753 | +28.9% | 42,194 | +5.5% | 2.99% | +23.7% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $6,161,466 | -9.3% | 43,621 | +0.5% | 2.70% | -13.0% |
| ABT | Buy | ABBOTT LABS | $5,509,336 | +96.8% | 75,100 | +63.6% | 2.42% | +88.9% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $5,493,453 | -6.1% | 119,371 | -11.0% | 2.41% | -9.9% |
| ENSG | Sell | ENSIGN GROUP INC | $5,112,177 | -14.2% | 134,655 | -18.9% | 2.24% | -17.6% |
| DHR | New | DANAHER CORP DEL | $3,874,427 | – | 35,604 | +100.0% | 1.70% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $2,768,555 | – | 209,739 | +100.0% | 1.22% | – |
| MDT | New | MEDTRONIC PLC | $2,649,716 | – | 26,800 | +100.0% | 1.16% | – |
| ANAB | Sell | ANAPTYSBIO INC | $2,247,219 | -3.1% | 22,524 | -31.0% | 0.99% | -7.0% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $2,012,822 | +59.9% | 9,400 | +108.9% | 0.88% | +53.3% |
| WMGI | New | WRIGHT MED GROUP N V | $1,932,732 | – | 66,600 | +100.0% | 0.85% | – |
| AFMD | Buy | AFFIMED N V | $1,882,362 | +194.9% | 432,727 | +11.9% | 0.83% | +182.9% |
| ARGX | Sell | ARGENX SEsponsored adr | $1,786,335 | -11.6% | 23,554 | -3.4% | 0.78% | -15.2% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $1,783,245 | -17.6% | 100,295 | +1.9% | 0.78% | -20.9% |
| ARQL | Sell | ARQULE INC | $1,639,238 | -20.8% | 289,618 | -22.6% | 0.72% | -24.1% |
| IVC | Buy | INVACARE CORP | $1,584,524 | -14.7% | 108,902 | +9.0% | 0.70% | -18.2% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $1,568,971 | +191.3% | 273,817 | +154.7% | 0.69% | +180.1% |
| ABMD | Sell | ABIOMED INC | $1,537,695 | -32.8% | 3,419 | -38.9% | 0.68% | -35.5% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $1,350,166 | -32.5% | 19,054 | -36.6% | 0.59% | -35.1% |
| BSTC | New | BIOSPECIFICS TECHNOLOGIES CO | $1,280,931 | – | 21,900 | +100.0% | 0.56% | – |
| MODN | Buy | MODEL N INC | $1,145,686 | +174.2% | 72,283 | +221.8% | 0.50% | +163.4% |
| BCRX | BIOCRYST PHARMACEUTICALS | $1,136,557 | +33.2% | 148,959 | 0.0% | 0.50% | +27.9% | |
| SPPI | New | SPECTRUM PHARMACEUTICALS INCput | $1,008,000 | – | 60,000 | +100.0% | 0.44% | – |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $993,615 | -29.8% | 21,671 | -9.4% | 0.44% | -32.6% |
| FOLD | New | AMICUS THERAPEUTICS INC | $964,178 | – | 79,750 | +100.0% | 0.42% | – |
| PODD | New | INSULET CORP | $928,652 | – | 8,765 | +100.0% | 0.41% | – |
| CTRE | Sell | CARETRUST REIT INC | $918,395 | -46.3% | 51,264 | -49.4% | 0.40% | -48.5% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $918,262 | +13.0% | 60,412 | +24.8% | 0.40% | +8.3% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $798,824 | -44.4% | 72,096 | -32.7% | 0.35% | -46.6% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $779,389 | -25.1% | 51,074 | -39.9% | 0.34% | -28.2% |
| TCDA | New | TRICIDA INC | $736,927 | – | 24,122 | +100.0% | 0.32% | – |
| KIDS | New | ORTHOPEDIATRICS CORP | $718,144 | – | 19,600 | +100.0% | 0.32% | – |
| SGMO | New | SANGAMO THERAPEUTICS INCcall | $678,000 | – | 40,000 | +100.0% | 0.30% | – |
| SPPI | New | SPECTRUM PHARMACEUTICALS INCcall | $672,000 | – | 40,000 | +100.0% | 0.30% | – |
| ANTM | Sell | ANTHEM INC | $630,315 | -47.0% | 2,300 | -54.0% | 0.28% | -49.1% |
| XRAY | New | DENTSPLY SIRONA INC | $630,963 | – | 16,680 | +100.0% | 0.28% | – |
| CNC | Sell | CENTENE CORP DEL | $622,554 | -36.8% | 4,300 | -46.2% | 0.27% | -39.5% |
| ALBO | ALBIREO PHARMA INC | $594,236 | -7.2% | 18,029 | 0.0% | 0.26% | -10.9% | |
| EPZM | EPIZYME INC | $502,959 | -21.8% | 47,449 | 0.0% | 0.22% | -24.8% | |
| MDCO | Sell | MEDICINES CO | $500,005 | -65.3% | 16,717 | -57.5% | 0.22% | -66.8% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $496,575 | -29.5% | 44,140 | -19.7% | 0.22% | -32.3% |
| SPNE | SEASPINE HLDGS CORP | $480,788 | +23.3% | 30,899 | 0.0% | 0.21% | +18.5% | |
| VKTX | New | VIKING THERAPEUTICS INC | $435,500 | – | 25,000 | +100.0% | 0.19% | – |
| DERM | Buy | DERMIRA INC | $436,196 | +136.8% | 40,018 | +99.9% | 0.19% | +127.4% |
| TGTX | Sell | TG THERAPEUTICS INC | $364,000 | -65.4% | 65,000 | -18.8% | 0.16% | -66.7% |
| OPHT | OPHTHOTECH CORP | $351,876 | -13.6% | 149,100 | 0.0% | 0.15% | -17.2% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $334,800 | -18.7% | 27,000 | 0.0% | 0.15% | -21.8% | |
| FOMX | New | FOAMIX PHARMACEUTICALS LTDput | $143,250 | – | 25,000 | +100.0% | 0.06% | – |
| CFMS | CONFORMIS INC | $134,462 | -15.2% | 126,851 | 0.0% | 0.06% | -19.2% | |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $105,850 | – | 14,500 | +100.0% | 0.05% | – |
| MLNT | Sell | MELINTA THERAPEUTICS INC | $104,592 | -78.6% | 26,479 | -65.5% | 0.05% | -79.4% |
| VTL | New | VITAL THERAPIES INCput | $10,548 | – | 38,300 | +100.0% | 0.01% | – |
| QCP | Exit | QUALITY CARE PROPERTIES ORDput | $0 | – | -1,800 | -100.0% | -0.02% | – |
| GLMD | Exit | GALMED PHARMACEUTICALS LTD | $0 | – | -10,000 | -100.0% | -0.05% | – |
| MGLN | Exit | MAGELLAN HEALTH INC | $0 | – | -3,000 | -100.0% | -0.13% | – |
| IRMD | Exit | IRADIMED CORP | $0 | – | -17,608 | -100.0% | -0.17% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -9,536 | -100.0% | -0.17% | – |
| CYAD | Exit | CELYAD SAadr | $0 | – | -12,840 | -100.0% | -0.18% | – |
| CDMO | Exit | AVID BIOSERVICES INC | $0 | – | -100,402 | -100.0% | -0.18% | – |
| QCP | Exit | QUALITY CARE PROPERTIES ORDcall | $0 | – | -20,000 | -100.0% | -0.20% | – |
| ZGNX | Exit | ZOGENIX INCcall | $0 | – | -10,000 | -100.0% | -0.20% | – |
| IIN | Exit | INTRICON CORP | $0 | – | -12,000 | -100.0% | -0.22% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -13,800 | -100.0% | -0.28% | – |
| ABUS | Exit | ARBUTUS BIOPHARMA CORP | $0 | – | -97,495 | -100.0% | -0.33% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -74,837 | -100.0% | -0.33% | – |
| CLLS | Exit | CELLECTIS S Asponsored ads | $0 | – | -30,000 | -100.0% | -0.39% | – |
| AKRXQ | Exit | AKORN INC | $0 | – | -70,000 | -100.0% | -0.53% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -56,546 | -100.0% | -0.57% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -25,950 | -100.0% | -0.59% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -55,000 | -100.0% | -0.60% | – |
| HAE | Exit | HAEMONETICS CORP | $0 | – | -14,646 | -100.0% | -0.60% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -61,300 | -100.0% | -0.62% | – |
| TSRO | Exit | TESARO INC | $0 | – | -52,523 | -100.0% | -1.07% | – |
| ATHN | Exit | ATHENAHEALTH INC | $0 | – | -16,000 | -100.0% | -1.16% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -47,279 | -100.0% | -1.73% | – |
| ZGNX | Exit | ZOGENIX INCput | $0 | – | -123,300 | -100.0% | -2.49% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -63,493 | -100.0% | -2.86% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -84,257 | -100.0% | -3.63% | – |
| QCP | Exit | QUALITY CARE PPTYS INC | $0 | – | -1,074,080 | -100.0% | -10.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.